Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026)

Elanco Animal Health (ELAN) reported Amortization - Intangibles of $138.0 million for Q1 2026, up 7.81% on a YoY basis from $128.0 million in Q1 2025, and down 0.72% sequentially from $139.0 million in Q4 2025.

Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Amortization - Intangibles data on file, last reported at $138.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortization - Intangibles rose 7.81% year-over-year to $138.0 million; the trailing twelve-month figure through Mar 2026 stood at $553.0 million (up 5.94% YoY), and the FY2025 full-year result was $543.0 million, up 3.04% from the prior year.
  • Amortization - Intangibles retreated to $138.0 million in Q1 2026, from $139.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $140.0 million in Q3 2023 to a low of $128.0 million in Q3 2022.
  • A 5-year average of $134.4 million and a median of $134.0 million in 2023 frame the typical range for Amortization - Intangibles.
  • Across the five-year window, Amortization - Intangibles dropped 9.22% in 2022 and increased 9.38% in 2023, its largest moves.
  • Tracing ELAN's Amortization - Intangibles over 5 years: stood at $130.0 million in 2022, then climbed by 6.15% to $138.0 million in 2023, then slipped by 5.8% to $130.0 million in 2024, then gained by 6.92% to $139.0 million in 2025, then dropped by 0.72% to $138.0 million in 2026.
  • Business Quant data shows ELAN's Amortization - Intangibles at $138.0 million in Q1 2026, $139.0 million in Q4 2025, and $140.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 138.00 Mn
Dec 31, 2025 139.00 Mn
Sep 30, 2025 140.00 Mn
Jun 30, 2025 136.00 Mn
Mar 31, 2025 128.00 Mn
Dec 31, 2024 130.00 Mn
Sep 30, 2024 133.00 Mn
Jun 30, 2024 131.00 Mn
Mar 31, 2024 133.00 Mn
Dec 31, 2023 138.00 Mn
Sep 30, 2023 140.00 Mn
Jun 30, 2023 136.00 Mn
Mar 31, 2023 134.00 Mn
Dec 31, 2022 130.00 Mn
Sep 30, 2022 128.00 Mn
Jun 30, 2022 133.00 Mn
Mar 31, 2022 137.00 Mn
Dec 31, 2021 139.00 Mn
Sep 30, 2021 141.00 Mn
Jun 30, 2021 129.00 Mn